Tweet
Infect Dis Clin North Am. 2013 Mar;27(1):19-31. doi: 10.1016/j.idc.2012.11.003. Epub 2012 Dec 6.
Biomarkers: What is Their Benefit in the Identification of Infection, Severity Assessment, and Management of Community-acquired Pneumonia?
Upadhyay S, Niederman MS.
Source
Pulmonary and Critical Care Medicine, Winthrop-University Hospital, Mineola, NY 11501, USA.
Abstract
Biomarkers have been proposed as tools that can guide the management of patients with community-acquired pneumonia, providing information that supplements the usually available clinical data. Among the available biomarkers, procalcitonin has been studied extensively and seems promising for several purposes. The use of biomarkers needs further study, to validate their utility in daily practice, especially given the limitations of the current tools for identifying the need for antibiotic therapy in patients with influenza and secondary bacterial pneumonia, in patients with aspiration syndromes, and in those infected with atypical pathogens.
Copyright ? 2013 Elsevier Inc. All rights reserved.
PMID:
23398863
[PubMed - in process]
Biomarkers: What is Their Benefit in the Identification of Infection, Severity Assessment, and Management of Community-acquired Pneumonia?
Upadhyay S, Niederman MS.
Source
Pulmonary and Critical Care Medicine, Winthrop-University Hospital, Mineola, NY 11501, USA.
Abstract
Biomarkers have been proposed as tools that can guide the management of patients with community-acquired pneumonia, providing information that supplements the usually available clinical data. Among the available biomarkers, procalcitonin has been studied extensively and seems promising for several purposes. The use of biomarkers needs further study, to validate their utility in daily practice, especially given the limitations of the current tools for identifying the need for antibiotic therapy in patients with influenza and secondary bacterial pneumonia, in patients with aspiration syndromes, and in those infected with atypical pathogens.
Copyright ? 2013 Elsevier Inc. All rights reserved.
PMID:
23398863
[PubMed - in process]
